FI922875A7 - Reniiniä estävät yhdisteet, menetelmä niiden valmistamiseksi ja niidenkäyttö - Google Patents

Reniiniä estävät yhdisteet, menetelmä niiden valmistamiseksi ja niidenkäyttö Download PDF

Info

Publication number
FI922875A7
FI922875A7 FI922875A FI922875A FI922875A7 FI 922875 A7 FI922875 A7 FI 922875A7 FI 922875 A FI922875 A FI 922875A FI 922875 A FI922875 A FI 922875A FI 922875 A7 FI922875 A7 FI 922875A7
Authority
FI
Finland
Prior art keywords
renin
preparation
inhibiting compounds
inhibiting
compounds
Prior art date
Application number
FI922875A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI922875A0 (fi
FI922875L (fi
Inventor
Hansjörg Urbach
Wolfgang Linz
Dieter Ruppert
Rainer Henning
Holger Heitsch
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI922875A0 publication Critical patent/FI922875A0/fi
Publication of FI922875L publication Critical patent/FI922875L/fi
Publication of FI922875A7 publication Critical patent/FI922875A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI922875A 1991-06-21 1992-06-18 Reniiniä estävät yhdisteet, menetelmä niiden valmistamiseksi ja niidenkäyttö FI922875A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4120510 1991-06-21

Publications (3)

Publication Number Publication Date
FI922875A0 FI922875A0 (fi) 1992-06-18
FI922875L FI922875L (fi) 1992-12-22
FI922875A7 true FI922875A7 (fi) 1992-12-22

Family

ID=6434452

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922875A FI922875A7 (fi) 1991-06-21 1992-06-18 Reniiniä estävät yhdisteet, menetelmä niiden valmistamiseksi ja niidenkäyttö

Country Status (14)

Country Link
EP (1) EP0519433A1 (enExample)
JP (1) JPH05186461A (enExample)
KR (1) KR930000506A (enExample)
CN (1) CN1068112A (enExample)
BR (1) BR9202325A (enExample)
CA (1) CA2071744A1 (enExample)
CZ (1) CZ190692A3 (enExample)
FI (1) FI922875A7 (enExample)
HU (1) HUT61744A (enExample)
IE (1) IE921995A1 (enExample)
MX (1) MX9203070A (enExample)
NO (1) NO922426L (enExample)
PL (1) PL294870A1 (enExample)
ZA (1) ZA924522B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888992A (en) 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
BR9306058A (pt) 1992-03-11 1997-11-18 Narhex Ltd Derivados de amina de hidrocarbonetos oxo- e hidroxi- substituidos
DE69333270T2 (de) 1992-03-11 2004-08-05 Narhex Ltd. Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
US6071895A (en) 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
IL110898A0 (en) * 1993-09-10 1994-11-28 Narhex Australia Pty Ltd Polar-substituted hydrocarbons
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6133256A (en) * 1997-04-14 2000-10-17 Cor Therapeutics Inc Selective factor Xa inhibitors
US6369063B1 (en) 1997-04-14 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
EP0977772A1 (en) 1997-04-14 2000-02-09 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6399599B1 (en) 1999-10-13 2002-06-04 Novartis Ag Substituted 2-oxo-1,4-diazacycloalkanes
ECSP003707A (es) * 1999-10-13 2002-05-23 Novartis Ag Diazepanes
HUP0304058A2 (hu) 2001-01-30 2004-04-28 Bristol-Myers Squibb Company Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
DE602005025344D1 (de) * 2004-01-23 2011-01-27 Novartis Ag Aminoalkoholderivate und deren wirkung als renininhibitoren
BRPI0506490A (pt) * 2004-01-23 2007-02-13 Speedel Experimenta Ag compostos orgánicos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81234A (en) * 1986-01-16 1992-09-06 Abbott Lab Peptidylaminodiols,process for their preparation and pharmaceutical compositions comprising them
GB8707412D0 (en) * 1987-03-27 1987-04-29 Fujisawa Pharmaceutical Co Peptide compounds
IL87614A0 (en) * 1987-09-16 1989-01-31 Abbott Lab Peptidylheterocycles
ATE165085T1 (de) * 1987-09-29 1998-05-15 Banyu Pharma Co Ltd N-acylaminosäurederivate und deren verwendung
IL92011A0 (en) * 1988-10-19 1990-07-12 Abbott Lab Heterocyclic peptide renin inhibitors
DE3839559A1 (de) * 1988-11-24 1990-05-31 Hoechst Ag Renin-hemmende aminodiol-derivate
DE3841732A1 (de) * 1988-12-10 1990-06-13 Hoechst Ag Dipeptid-derivate mit enzym-inhibitorischer wirkung
DE3913272A1 (de) * 1989-04-22 1990-10-25 Hoechst Ag Dipeptid-derivate mit enzym-inhibitorischer wirkung

Also Published As

Publication number Publication date
FI922875A0 (fi) 1992-06-18
IE921995A1 (en) 1992-12-30
NO922426D0 (no) 1992-06-19
FI922875L (fi) 1992-12-22
HUT61744A (en) 1993-03-01
PL294870A1 (enExample) 1993-02-08
KR930000506A (ko) 1993-01-15
HU9202062D0 (en) 1992-10-28
JPH05186461A (ja) 1993-07-27
EP0519433A1 (de) 1992-12-23
BR9202325A (pt) 1993-01-19
NO922426L (no) 1992-12-22
CA2071744A1 (en) 1992-12-22
ZA924522B (en) 1993-02-24
CZ190692A3 (en) 1993-01-13
MX9203070A (es) 1992-12-01
CN1068112A (zh) 1993-01-20

Similar Documents

Publication Publication Date Title
FI941538L (fi) Partikkelit, menetelmä niiden valmistamiseksi ja niiden käyttö
FI960751A7 (fi) Substituoidut atsaindolylideeniyhdisteet ja menetelmä niiden valmistamiseksi
FI924054A7 (fi) Imidatsoliin liitetyt iso- ja heterosyklit, menetelmä niiden valmistamiseksi ja niiden käyttö
FI962917A7 (fi) Mikrokapselit, menetelmä niiden valmistamiseksi, ja niiden käyttö
FI962954A7 (fi) Substituoidut 3-arylideeni-7-atsaoksindoliyhdisteet ja menetelmä niiden valmistamiseksi
FI941137A7 (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
FI921943A7 (fi) Huokoinen mehiläiskennomateriaali, menetelmä sen valmistamiseksi ja sen käyttö
FI973426L (fi) Bentsopyraania sisältävät yhdisteet ja menetelmä niiden valmistamiseksi
FI935465L (fi) Termoplastinen koostumus, menetelmä sen valmistamiseksi ja sen käyttö
FI951468L (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
MX9201355A (es) Bis-naftal imidas y metodo para su preparacion.
FI905171A7 (fi) Kinoloniyhdisteet ja menetelmä niiden valmistamiseksi
FI934141A7 (fi) Antikoagulantit ja menetelmiä niiden valmistamiseksi
FI943207A7 (fi) 4,5-dihydrogeldanamysiinin ja sen hydrokinonin valmistusmenetelmä ja k äyttö
FI921525A7 (fi) Amidinofenyylialaniinijohdannaisia, menetelmä niiden valmistamiseksi, niiden käyttö ja niitä sisältäviä aineita
FI915381A7 (fi) Substituoituja atsoleja, menetelmä niiden valmistamiseksi ja niiden käyttö
FI940775L (fi) alfa-fenyyli-isoseriinijohdannaisten valmistusmentelmä ja niiden käyttö
FI910696A7 (fi) SiO2-himmennysaine, menetelmä sen valmistamiseksi ja sen käyttö
FI970997A7 (fi) Bentsosykloalkeeniyhdisteet, niiden valmistus ja käyttö
FI951631L (fi) Substituoituja kynureniinejä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
FI923755A7 (fi) Disulfideja, menetelmiä niiden valmistamiseksi ja niiden käyttö
FI941914A0 (fi) 2-amino-4-kinoliinidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö
FI905172A7 (fi) Kinoloniyhdisteet ja menetelmä niiden valmistamiseksi
FI953956A7 (fi) 2,3-rengaskondensoidut 1,4-dihydropyridiinit, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
FI955123A0 (fi) Kolestyramiinia sisältävä koostumus ja menetelmä tämän valmistamiseksi